Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP730910.RAfuYDDBca-CcLiW1xeD7gFKuYL10ukn4bjxxNJR4U044130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP730910.RAfuYDDBca-CcLiW1xeD7gFKuYL10ukn4bjxxNJR4U044130_assertion type Assertion NP730910.RAfuYDDBca-CcLiW1xeD7gFKuYL10ukn4bjxxNJR4U044130_head.
- NP730910.RAfuYDDBca-CcLiW1xeD7gFKuYL10ukn4bjxxNJR4U044130_assertion description "[To develop gene therapy targeting thyroid carcinoma, the recombinant retrovirus (LNTGTK) carrying herpes simplex virus thymidine kinase (HSV-TK) gene under the control of thyroglobulin (TG) promoter was constructed and its efficacy was investigated in 3 thyroid cell lines; a differentiated normal rat thyroid cell line (FRTL5), malignant rat thyroid carcinoma cells derived from FRTL5 (FRTC) and a human anaplastic thyroid carcinoma cell line (FRO).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP730910.RAfuYDDBca-CcLiW1xeD7gFKuYL10ukn4bjxxNJR4U044130_provenance.
- NP730910.RAfuYDDBca-CcLiW1xeD7gFKuYL10ukn4bjxxNJR4U044130_assertion evidence source_evidence_literature NP730910.RAfuYDDBca-CcLiW1xeD7gFKuYL10ukn4bjxxNJR4U044130_provenance.
- NP730910.RAfuYDDBca-CcLiW1xeD7gFKuYL10ukn4bjxxNJR4U044130_assertion SIO_000772 9724055 NP730910.RAfuYDDBca-CcLiW1xeD7gFKuYL10ukn4bjxxNJR4U044130_provenance.
- NP730910.RAfuYDDBca-CcLiW1xeD7gFKuYL10ukn4bjxxNJR4U044130_assertion wasDerivedFrom befree-20150227 NP730910.RAfuYDDBca-CcLiW1xeD7gFKuYL10ukn4bjxxNJR4U044130_provenance.
- NP730910.RAfuYDDBca-CcLiW1xeD7gFKuYL10ukn4bjxxNJR4U044130_assertion wasGeneratedBy ECO_0000203 NP730910.RAfuYDDBca-CcLiW1xeD7gFKuYL10ukn4bjxxNJR4U044130_provenance.